JENKINS DAVID A

SEC source: 0001437749-26-010382 · rdgdoc.xml · derivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 40,000

Underlying: Common Stock · 40,000 shares

Expires 2036-03-26

F1 · derivative.exercise_date: Options vest 100% on 180 day anniversary of grant date.

SEC source: 0001437749-26-004551 · rdgdoc.xml · derivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Director · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 6,998.195

Underlying: Common Stock · 4,486,022 shares

Expires not disclosed

F1 · kind: Series J Exchange Agreement entered into with the Company to cancel accrued royalty amount and terminate royalty right in exchange for Series J Preferred Stock, as more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2026 (the "Form 8-K").

F4 · price: The consideration and price paid for the Series J Preferred Stock is more fully described in the Form 8-K.

F2 · derivative.exercise_date: Series J Preferred Stock is not exercisable until stockholder approval is received, as more fully described in the Form 8-K.

F3 · derivative.expiration_date: Series J Preferred Stock has no expiration date.

F5 · ownership.nature: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP.

SEC source: 0001437749-26-004551 · rdgdoc.xml · derivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,491.293

Underlying: Common Stock · 1,596,983 shares

Expires not disclosed

F1 · kind: Series J Exchange Agreement entered into with the Company to cancel accrued royalty amount and terminate royalty right in exchange for Series J Preferred Stock, as more fully described in the Current Report on Form 8-K filed with the Securities and Exchange Commission on February 12, 2026 (the "Form 8-K").

F4 · price: The consideration and price paid for the Series J Preferred Stock is more fully described in the Form 8-K.

F2 · derivative.exercise_date: Series J Preferred Stock is not exercisable until stockholder approval is received, as more fully described in the Form 8-K.

F3 · derivative.expiration_date: Series J Preferred Stock has no expiration date.

SEC source: 0001437749-26-001574 · rdgdoc.xml · derivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote 3

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Initial Exercise Date is any time on or after the Stockholder Approval Date.

F2 · derivative.expiration_date: Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date

F3 · ownership.nature: Mr. Jenkins is the managing member of SeaCap Management LLC, the general partner of FatBoy Capital LP

SEC source: 0001437749-26-001574 · rdgdoc.xml · derivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,000

Underlying: Common Stock · 170,000 shares

Expires not disclosed

F1 · derivative.exercise_date: Initial Exercise Date is any time on or after the Stockholder Approval Date.

F2 · derivative.expiration_date: Termination Date equals the Five and One Half (5.5) Year Anniversary of the Initial Exercise Date

SEC source: 0001437749-25-037162 · rdgdoc.xml · derivative · entry 6

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date

F2 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee

SEC source: 0001437749-25-037162 · rdgdoc.xml · derivative · entry 5

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date

F1 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner

SEC source: 0001437749-25-037162 · rdgdoc.xml · derivative · entry 4

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 0 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date

SEC source: 0001437749-25-037162 · rdgdoc.xml · nonDerivative · entry 3

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 109

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee

SEC source: 0001437749-25-037162 · rdgdoc.xml · nonDerivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Indirect · See Footnote

Disclosed balance after: 34,579

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner

SEC source: 0001437749-25-037162 · rdgdoc.xml · nonDerivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,799

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001654954-25-009658 · section16.xml · derivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Exec. Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 500,000

Underlying: Common Stock · 500,000 shares

Expires 2035-08-12

F1 · derivative.exercise_date: Options vests 20% per year beginning on first anniversary of grant date.

SEC source: 0001437749-25-002432 · rdgdoc.xml · derivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Chairman of the Board and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,000

Underlying: Common stock · 450,000 shares

Expires 2035-01-29

F1 · derivative.exercise_date: 90,000 shares exercisable January 29, 2025, 120,000 shares exercisable January 29, 2026, 120,000 shares exercisable January 29, 2027, and 120,000 shares exercisable January 29, 2028.

SEC source: 0001654954-24-000874 · section16.xml · nonDerivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 329,856

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4164 to $0.4319, inclusive on January 22, 2024 and $0.5673 to $0.6304, inclusive on January 23, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

SEC source: 0001654954-24-000874 · section16.xml · nonDerivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,328

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.4164 to $0.4319, inclusive on January 22, 2024 and $0.5673 to $0.6304, inclusive on January 23, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

SEC source: 0001654954-24-000790 · section16.xml · nonDerivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 310,800

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3989 to $00.4174, inclusive on January 18, 2024 and $00.4211 to $00.4475, inclusive on January 19, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

SEC source: 0001654954-24-000790 · section16.xml · nonDerivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 302,330

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3989 to $00.4174, inclusive on January 18, 2024 and $00.4211 to $00.4475, inclusive on January 19, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

SEC source: 0001654954-24-000736 · section16.xml · nonDerivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 293,860

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3820 to $00.3923, inclusive on January 16, 2024 and $00.3898 to $00.3968, inclusive on January 17, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

SEC source: 0001654954-24-000736 · section16.xml · nonDerivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman and CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,390

F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $00.3820 to $00.3923, inclusive on January 16, 2024 and $00.3898 to $00.3968, inclusive on January 17, 2024. The reporting person undertakes to provide Catheter Precision, Inc., any security holder of Catheter Precision, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth above.

SEC source: 0001654954-23-003613 · section16.xml · derivative · entry 6

JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 18.691

Underlying: Common Stock · 18,691 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.

F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date.

F3 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.

SEC source: 0001654954-23-003613 · section16.xml · derivative · entry 5

JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 5,860.54

Underlying: Common Stock · 5,860,540 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.

F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date.

F2 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner.

SEC source: 0001654954-23-003613 · section16.xml · derivative · entry 4

JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,292.339

Underlying: Common Stock · 2,292,339 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: Each share of preferred stock will automatically convert into 1000 shares of common stock on or after July 9, 2024, if the Company satisfies the initial listing standards of a national securities exchange or has been delisted from the NYSE American.

F5 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date.

SEC source: 0001654954-23-003613 · section16.xml · nonDerivative · entry 3

JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 2,264

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.

F3 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.

SEC source: 0001654954-23-003613 · section16.xml · nonDerivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 709,703

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.

F2 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner.

SEC source: 0001654954-23-003613 · section16.xml · nonDerivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Ex. Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 277,597

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was the result of the automatic conversion of shares of Series X Preferred upon receipt of stockholder approval.

SEC source: 0001209191-23-003033 · doc4.xml · derivative · entry 3

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman of Board

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 6,570.243

Underlying: Common Stock · 6,570,243 shares

Expires not disclosed

F1 · derivative.exercise_price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F2 · kind: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).

F1 · price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F1 · derivative.exercise_date: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date

F5 · ownership.nature: Shares held by a partnership of which the reporting person is the managing member of the managing partner.

SEC source: 0001209191-23-003033 · doc4.xml · derivative · entry 2

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman of Board

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnote

Disclosed balance after: 20.955

Underlying: Common Stock · 20,955 shares

Expires not disclosed

F1 · derivative.exercise_price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F2 · kind: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).

F1 · price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F1 · derivative.exercise_date: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date

F4 · ownership.nature: Shares held by charitable remainder unitrust of which the reporting person's spouse is the trustee.

SEC source: 0001209191-23-003033 · doc4.xml · derivative · entry 1

JENKINS DAVID A · CIK 0001279803 · Director · Executive Chairman of Board

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,569.936

Underlying: Common Stock · 2,569,936 shares

Expires not disclosed

F1 · derivative.exercise_price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F2 · kind: On January 9, 2023, the Issuer, completed its acquisition of Catheter Precision, Inc., a privately-held Delaware corporation ("Catheter"), pursuant to an Amended and Restated Agreement and Plan of Merger (the "Merger"). In connection with the Merger, each share of Catheter common stock previously outstanding held by the reporting person now represents a number of shares of Series X Convertible Preferred Stock equal to approximately 0.6697, divided by one thousand (1,000).

F1 · price: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F1 · derivative.exercise_date: Following stockholder approval of the conversion of Series X Convertible Preferred Stock into shares of Common Stock, each share of Series X Convertible Preferred Stock automatically converts into 1,000 shares of Common Stock, subject to certain limitations.

F3 · derivative.expiration_date: Series X Convertible Preferred Stock has no expiration date